NO20074631L - Nye 3-aryl-1,2-benzisoksazolderivater, forbindelser inneholdende de samme og deres anvendelse - Google Patents

Nye 3-aryl-1,2-benzisoksazolderivater, forbindelser inneholdende de samme og deres anvendelse

Info

Publication number
NO20074631L
NO20074631L NO20074631A NO20074631A NO20074631L NO 20074631 L NO20074631 L NO 20074631L NO 20074631 A NO20074631 A NO 20074631A NO 20074631 A NO20074631 A NO 20074631A NO 20074631 L NO20074631 L NO 20074631L
Authority
NO
Norway
Prior art keywords
nitro
halogen
aryl
new
same
Prior art date
Application number
NO20074631A
Other languages
English (en)
Norwegian (no)
Inventor
Jean-Marie Ruxer
Chantal Carrez
Luc Bertin
Fabienne Thompson
Patrick Maillet
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35058405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074631(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20074631L publication Critical patent/NO20074631L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/423—Oxazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20074631A 2005-02-22 2007-09-11 Nye 3-aryl-1,2-benzisoksazolderivater, forbindelser inneholdende de samme og deres anvendelse NO20074631L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0501801A FR2882361A1 (fr) 2005-02-22 2005-02-22 Nouveaux derives de 3-aryl-1,2-benzisoxazole, compositions les contenant et leur utilisation
PCT/FR2006/000375 WO2006090052A1 (fr) 2005-02-22 2006-02-20 Nouveaux derives de 3-aryl-1 ,2-benzisoxazole, compositions les contenant et leur utilisation

Publications (1)

Publication Number Publication Date
NO20074631L true NO20074631L (no) 2007-11-20

Family

ID=35058405

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074631A NO20074631L (no) 2005-02-22 2007-09-11 Nye 3-aryl-1,2-benzisoksazolderivater, forbindelser inneholdende de samme og deres anvendelse

Country Status (19)

Country Link
US (1) US20080070960A1 (fr)
EP (1) EP1861381A1 (fr)
JP (1) JP2008531493A (fr)
KR (1) KR20070110102A (fr)
CN (1) CN101146780A (fr)
AR (1) AR053684A1 (fr)
AU (1) AU2006217799A1 (fr)
BR (1) BRPI0606178A2 (fr)
CA (1) CA2597781A1 (fr)
EA (1) EA200701798A1 (fr)
FR (1) FR2882361A1 (fr)
IL (1) IL185166A0 (fr)
MA (1) MA29265B1 (fr)
MX (1) MX2007010278A (fr)
NO (1) NO20074631L (fr)
TW (1) TW200640884A (fr)
UY (1) UY29390A1 (fr)
WO (1) WO2006090052A1 (fr)
ZA (1) ZA200707080B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2907453B1 (fr) * 2006-10-24 2008-12-26 Sanofi Aventis Sa Nouveaux derives du fluorene,compositions les contenant et utilisation
AR077405A1 (es) 2009-07-10 2011-08-24 Sanofi Aventis Derivados del indol inhibidores de hsp90, composiciones que los contienen y utilizacion de los mismos para el tratamiento del cancer
FR2949467B1 (fr) 2009-09-03 2011-11-25 Sanofi Aventis Nouveaux derives de 5,6,7,8-tetrahydroindolizine inhibiteurs d'hsp90, compositions les contenant et utilisation
HUE037312T2 (hu) * 2012-12-19 2018-08-28 Celgene Quanticel Res Inc Hiszton demetiláz inhibitorok

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884814B2 (en) * 2001-12-13 2005-04-26 Wyeth Phenyl benzisoxazoles as estrogenic agents
CA2515726C (fr) * 2003-02-11 2012-07-10 Vernalis (Cambridge) Limited Isoxazoles
CA2530374C (fr) * 2003-06-27 2012-05-15 Kyowa Hakko Kogyo Co., Ltd. Inhibiteur de proteines de la famille hsp90
US20060257987A1 (en) * 2003-08-20 2006-11-16 Gonzalez Valcarcel Isabel Cris Ppar modulators

Also Published As

Publication number Publication date
MA29265B1 (fr) 2008-02-01
CN101146780A (zh) 2008-03-19
CA2597781A1 (fr) 2006-08-31
UY29390A1 (es) 2006-10-02
AR053684A1 (es) 2007-05-16
AU2006217799A1 (en) 2006-08-31
EA200701798A1 (ru) 2008-02-28
TW200640884A (en) 2006-12-01
FR2882361A1 (fr) 2006-08-25
IL185166A0 (en) 2007-12-03
KR20070110102A (ko) 2007-11-15
ZA200707080B (en) 2008-11-26
EP1861381A1 (fr) 2007-12-05
MX2007010278A (es) 2007-11-07
BRPI0606178A2 (pt) 2009-06-02
JP2008531493A (ja) 2008-08-14
WO2006090052A1 (fr) 2006-08-31
US20080070960A1 (en) 2008-03-20

Similar Documents

Publication Publication Date Title
NO20076460L (no) Nye fluorenderivater, sammensetninger inneholdende nevnte derivater og anvendelse derav
NO20072053L (no) Nye bis-azaindolderivater, fremstilling og farmasoytisk anvendelse derav som kinaseinhibitorer
NO20063468L (no) Triazolforbindelser og deres anvendelse som metabotrofe glutamatreseptorantagonister
NO20076066L (no) Oksadiazolderivater som DGAT-inhibitorer
NO20061660L (no) 2-pyridonderivate som neutrofil elasaeinhibitor og deres anvendelse
NO20084845L (no) 2-pyrazinonderivater for behandling av sykdom eller tilstander der inhibiering av neutrofil elastaseaktivitetet er gunstig
NO20061700L (no) 2-pyridonderivater som neutrofil elastase inhibitorer og deres anvendelse
NO20092692L (no) MAPK/ERK kinaseinhibitorer
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20066055L (no) Pyridinderivater
NO20091141L (no) Pyrido (2,3-D) pyrimidinonforbindelser og deres anvendelse som P13 inhibitorer
NO20081217L (no) Nye benzotiazolonderivater
NO20090628L (no) Pyridizinon derivativater
NO20084872L (no) 2-pyridonderivater for behandling av sykdom eller tilstander der inhibering av neutrofil elastaseaktivitet er gunstig
NO20082388L (no) Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer
NO20070176L (no) Nye fluorglykosidderivater av pyrazoler, medikamenter inneholdende disse forbindelsene og anvendelse derav
NO20063469L (no) Polyeheterosykliske forbindelser og deres anvendelse som metabotrofe glutamat reseptorantagonister
NO20082934L (no) Antivirale nukleotider
NO20071074L (no) Substituerte cykliske ureaderivater, fremstilling derav og farmasoytisk anvendelse derav som kinaseinhibitorer
NO20083514L (no) Heterobicykliske sulfonamidderivater for behandling av diabetes
NO20081482L (no) Delta- og epsilon-krystallformer for imatinibmesylat
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
EA201791254A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
PE20110063A1 (es) DERIVADOS DE [1, 2, 4]TRIAZOLO[1, 5-a]PIRIDINA COMO INHIBIDORES DE JAK

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application